LARP6 and cancer: Studying translation regulation also holds the promise of uncovering new potent therapeutic strategies, such as with the ribosome biogenesis regulator LARP6 (Dermitet al., 2020), to target cell invasive activity more specifically in cancer and immune system disorders.